Design, Synthesis, and Biological Evaluation of Benzimidazol‐2‐One Hybrids as Potential Anti‐Alzheimer's Disease Agents

Fatih Yılmaz, Emre Menteşe, Ozan Emre Eyüpoğlu, Bahittin Kahveci, Mustafa Emirik

Open source

DOI
10.1002/ddr.70369
Published
2026-08-20
Container
Drug Development Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ddr.70369,
  title = {Design, Synthesis, and Biological Evaluation of Benzimidazol‐2‐One Hybrids as Potential Anti‐Alzheimer's Disease Agents},
  author = {Fatih Yılmaz and Emre Menteşe and Ozan Emre Eyüpoğlu and Bahittin Kahveci and Mustafa Emirik},
  year = {2026},
  journal = {Drug Development Research},
  doi = {10.1002/ddr.70369},
  url = {https://doi.org/10.1002/ddr.70369}
}

RIS

TY  - JOUR
TI  - Design, Synthesis, and Biological Evaluation of Benzimidazol‐2‐One Hybrids as Potential Anti‐Alzheimer's Disease Agents
AU  - Fatih Yılmaz
AU  - Emre Menteşe
AU  - Ozan Emre Eyüpoğlu
AU  - Bahittin Kahveci
AU  - Mustafa Emirik
PY  - 2026
JO  - Drug Development Research
DO  - 10.1002/ddr.70369
UR  - https://doi.org/10.1002/ddr.70369
ER  - 

APA

Yılmaz, F., Menteşe, E., Eyüpoğlu, O. E., Kahveci, B., & Emirik, M. (2026). Design, Synthesis, and Biological Evaluation of Benzimidazol‐2‐One Hybrids as Potential Anti‐Alzheimer's Disease Agents. Drug Development Research. https://doi.org/10.1002/ddr.70369

Source records